Cover Image

Pancreatic adenocarcinoma: long-term outcomes of adjuvant therapy in the ESPAC4 phase III Trial

Purpose - The ESPAC4 trial showed that adjuvant chemotherapy with gemcitabine plus capecitabine (GemCap) produced longer overall survival (OS) than gemcitabine monotherapy. Subsequently, the PRODIGE24-CCTG PA.6 trial showed even longer survival for modified fluorouracil, folinic acid, irinotecan, an...

Full description

Saved in:
Bibliographic Details
Main Authors: Palmer, Daniel (Author) , Jackson, Richard (Author) , Springfeld, Christoph (Author) , Ghaneh, Paula (Author) , Rawcliffe, Charlotte (Author) , Halloran, Christopher M. (Author) , Faluyi, Olusola (Author) , Cunningham, David (Author) , Wadsley, Jonathan (Author) , Darby, Suzanne (Author) , Meyer, Tim (Author) , Gillmore, Roopinder (Author) , Lind, Pehr (Author) , Glimelius, Bengt (Author) , Falk, Stephen (Author) , Ma, Yuk Ting (Author) , Middleton, Gary William (Author) , Cummins, Sebastian (Author) , Ross, Paul J. (Author) , Wasan, Harpreet (Author) , McDonald, Alec (Author) , Crosby, Tom (Author) , Hammel, Pascal (Author) , Borg, David (Author) , Sothi, Sharmila (Author) , Valle, Juan W. (Author) , Mehrabi, Arianeb (Author) , Bailey, Peter (Author) , Tjaden, Christine (Author) , Michalski, Christoph (Author) , Hackert, Thilo (Author) , Büchler, Markus W. (Author) , Neoptolemos, John P. (Author)
Format: Article (Journal)
Language:English
Published: 2025
In: Journal of clinical oncology
Year: 2025, Volume: 43, Issue: 10, Pages: 1240-1253
ISSN:1527-7755
DOI:10.1200/JCO.24.01118
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.1200/JCO.24.01118
Verlag, kostenfrei, Volltext: https://ascopubs.org/doi/10.1200/JCO.24.01118
Get full text
Author Notes:Daniel H. Palmer, Richard Jackson, Christoph Springfeld, Paula Ghaneh, Charlotte Rawcliffe, Christopher M. Halloran, Olusola Faluyi, David Cunningham, Jonathan Wadsley, Suzanne Darby, Tim Meyer, Roopinder Gillmore, Pehr Lind, Bengt Glimelius, Stephen Falk, Yuk Ting Ma, Gary William Middleton, Sebastian Cummins, Paul J. Ross, Harpreet Wasan, Alec McDonald, Tom Crosby, Pascal Hammel, David Borg, Sharmila Sothi, Juan W. Valle, Arianeb Mehrabi, Peter Bailey, Christine Tjaden, Christoph Michalski, Thilo Hackert, Markus W. Büchler, and John P. Neoptolemos

MARC

LEADER 00000caa a2200000 c 4500
001 1941262821
003 DE-627
005 20260108180211.0
007 cr uuu---uuuuu
008 251114s2025 xx |||||o 00| ||eng c
024 7 |a 10.1200/JCO.24.01118  |2 doi 
035 |a (DE-627)1941262821 
035 |a (DE-599)KXP1941262821 
035 |a (OCoLC)1559715017 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Palmer, Daniel  |e VerfasserIn  |0 (DE-588)1381596452  |0 (DE-627)1941263542  |4 aut 
245 1 0 |a Pancreatic adenocarcinoma  |b long-term outcomes of adjuvant therapy in the ESPAC4 phase III Trial  |c Daniel H. Palmer, Richard Jackson, Christoph Springfeld, Paula Ghaneh, Charlotte Rawcliffe, Christopher M. Halloran, Olusola Faluyi, David Cunningham, Jonathan Wadsley, Suzanne Darby, Tim Meyer, Roopinder Gillmore, Pehr Lind, Bengt Glimelius, Stephen Falk, Yuk Ting Ma, Gary William Middleton, Sebastian Cummins, Paul J. Ross, Harpreet Wasan, Alec McDonald, Tom Crosby, Pascal Hammel, David Borg, Sharmila Sothi, Juan W. Valle, Arianeb Mehrabi, Peter Bailey, Christine Tjaden, Christoph Michalski, Thilo Hackert, Markus W. Büchler, and John P. Neoptolemos 
264 1 |c 2025 
300 |b Diagramme 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Online veröffentlicht: 4. Dezember 2024 
500 |a Gesehen am 14.11.2025 
520 |a Purpose - The ESPAC4 trial showed that adjuvant chemotherapy with gemcitabine plus capecitabine (GemCap) produced longer overall survival (OS) than gemcitabine monotherapy. Subsequently, the PRODIGE24-CCTG PA.6 trial showed even longer survival for modified fluorouracil, folinic acid, irinotecan, and oxaliplatin (mFOLFIRINOX) than gemcitabine but had more restrictive eligibility criteria. Our aim was to analyze the ESPAC4 survival on long-term follow-up. - Methods - The OS of 732 ESPAC4 patients comparing 367 randomly assigned to gemcitabine and 365 to GemCap was previously reported after a median follow-up time of 43.2 months (95% CI, 39.7 to 45.5) and 458 deaths. Analysis was now carried out after a median follow-up of 104 months (101-108) and 566 deaths. - Results - The median OS was 29.5 months (27.5-32.1) for all patients, 28.4 months (25.2-32.0) in the gemcitabine group and 31.6 months (26.5-38.0) in the GemCap group (hazard ratio [HR], 0.83 [0.71 to 0.98]; P = .031). R0 patients given gemcitabine had a median survival of 32.2 months (27.9-41.6) compared with 49.9 months (39.0-82.3) for those given GemCap (HR, 0.63 [0.47 to 0.84]; P = .002). Lymph node-negative patients had significantly higher 5 year OS rates on GemCap (59% [49%-71%]) than gemcitabine (53% [42%-66%]; HR, 0.63 [0.41 to 0.98]; P = .04) but not those with positive lymph nodes (P = .225). The OS advantage for GemCap was retained in the PRODIGE24 subgroup of 193 (26.4%) ESPAC4 patients not eligible for PRODIGE24 with a median survival of 20.7 (16.2-27.3) months in patients allocated to gemcitabine compared with 25.9 (22.3-30.2) months for ineligible patients allocated to GemCap (HR, 0.71 [95% CI, 0.52 to 0.98]; χ2log-rank-1df = 4.31; P = .038). - Conclusion - GemCap is a standard option for patients not eligible for mFOLFIRINOX. Exploratory evidence suggests that GemCap may be particularly efficacious in R0 patients and also in lymph node-negative patients. 
700 1 |a Jackson, Richard  |e VerfasserIn  |0 (DE-588)1386212555  |0 (DE-627)194809469X  |4 aut 
700 1 |a Springfeld, Christoph  |d 1972-  |e VerfasserIn  |0 (DE-588)123388910  |0 (DE-627)706281039  |0 (DE-576)293689385  |4 aut 
700 1 |a Ghaneh, Paula  |e VerfasserIn  |4 aut 
700 1 |a Rawcliffe, Charlotte  |e VerfasserIn  |4 aut 
700 1 |a Halloran, Christopher M.  |e VerfasserIn  |4 aut 
700 1 |a Faluyi, Olusola  |e VerfasserIn  |4 aut 
700 1 |a Cunningham, David  |e VerfasserIn  |4 aut 
700 1 |a Wadsley, Jonathan  |e VerfasserIn  |4 aut 
700 1 |a Darby, Suzanne  |e VerfasserIn  |4 aut 
700 1 |a Meyer, Tim  |e VerfasserIn  |4 aut 
700 1 |a Gillmore, Roopinder  |e VerfasserIn  |4 aut 
700 1 |a Lind, Pehr  |e VerfasserIn  |4 aut 
700 1 |a Glimelius, Bengt  |e VerfasserIn  |4 aut 
700 1 |a Falk, Stephen  |e VerfasserIn  |4 aut 
700 1 |a Ma, Yuk Ting  |e VerfasserIn  |4 aut 
700 1 |a Middleton, Gary William  |e VerfasserIn  |4 aut 
700 1 |a Cummins, Sebastian  |e VerfasserIn  |4 aut 
700 1 |a Ross, Paul J.  |e VerfasserIn  |4 aut 
700 1 |a Wasan, Harpreet  |e VerfasserIn  |4 aut 
700 1 |a McDonald, Alec  |e VerfasserIn  |4 aut 
700 1 |a Crosby, Tom  |e VerfasserIn  |4 aut 
700 1 |a Hammel, Pascal  |e VerfasserIn  |4 aut 
700 1 |a Borg, David  |e VerfasserIn  |4 aut 
700 1 |a Sothi, Sharmila  |e VerfasserIn  |4 aut 
700 1 |a Valle, Juan W.  |e VerfasserIn  |4 aut 
700 1 |a Mehrabi, Arianeb  |d 1967-  |e VerfasserIn  |0 (DE-588)137664583  |0 (DE-627)594829763  |0 (DE-576)304831263  |4 aut 
700 1 |a Bailey, Peter  |e VerfasserIn  |4 aut 
700 1 |a Tjaden, Christine  |e VerfasserIn  |4 aut 
700 1 |a Michalski, Christoph  |d 1977-  |e VerfasserIn  |0 (DE-588)129922250  |0 (DE-627)483655848  |0 (DE-576)297904302  |4 aut 
700 1 |a Hackert, Thilo  |d 1971-  |e VerfasserIn  |0 (DE-588)122158512  |0 (DE-627)70579346X  |0 (DE-576)182659208  |4 aut 
700 1 |a Büchler, Markus W.  |d 1955-  |e VerfasserIn  |0 (DE-588)120893339  |0 (DE-627)080952526  |0 (DE-576)292434146  |4 aut 
700 1 |a Neoptolemos, John P.  |e VerfasserIn  |0 (DE-588)172283302  |0 (DE-627)697192954  |0 (DE-576)133150879  |4 aut 
773 0 8 |i Enthalten in  |t Journal of clinical oncology  |d Alexandria, Va. : American Society of Clinical Oncology, 1983  |g 43(2025), 10, Seite 1240-1253  |h Online-Ressource  |w (DE-627)313116962  |w (DE-600)2005181-5  |w (DE-576)090887018  |x 1527-7755  |7 nnas  |a Pancreatic adenocarcinoma long-term outcomes of adjuvant therapy in the ESPAC4 phase III Trial 
773 1 8 |g volume:43  |g year:2025  |g number:10  |g pages:1240-1253  |g extent:14  |a Pancreatic adenocarcinoma long-term outcomes of adjuvant therapy in the ESPAC4 phase III Trial 
856 4 0 |u https://doi.org/10.1200/JCO.24.01118  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext  |7 0 
856 4 0 |u https://ascopubs.org/doi/10.1200/JCO.24.01118  |x Verlag  |z kostenfrei  |3 Volltext  |7 0 
951 |a AR 
992 |a 20251114 
993 |a Article 
994 |a 2025 
998 |g 172283302  |a Neoptolemos, John P.  |m 172283302:Neoptolemos, John P.  |d 910000  |d 910200  |e 910000PN172283302  |e 910200PN172283302  |k 0/910000/  |k 1/910000/910200/  |p 33  |y j 
998 |g 120893339  |a Büchler, Markus W.  |m 120893339:Büchler, Markus W.  |d 910000  |d 910200  |e 910000PB120893339  |e 910200PB120893339  |k 0/910000/  |k 1/910000/910200/  |p 32 
998 |g 122158512  |a Hackert, Thilo  |m 122158512:Hackert, Thilo  |d 50000  |e 50000PH122158512  |k 0/50000/  |p 31 
998 |g 129922250  |a Michalski, Christoph  |m 129922250:Michalski, Christoph  |d 910000  |d 910200  |d 50000  |e 910000PM129922250  |e 910200PM129922250  |e 50000PM129922250  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 30 
998 |g 137664583  |a Mehrabi, Arianeb  |m 137664583:Mehrabi, Arianeb  |d 910000  |d 910200  |d 50000  |e 910000PM137664583  |e 910200PM137664583  |e 50000PM137664583  |k 0/910000/  |k 1/910000/910200/  |k 0/50000/  |p 27 
998 |g 123388910  |a Springfeld, Christoph  |m 123388910:Springfeld, Christoph  |d 910000  |d 910100  |d 50000  |e 910000PS123388910  |e 910100PS123388910  |e 50000PS123388910  |k 0/910000/  |k 1/910000/910100/  |k 0/50000/  |p 3 
999 |a KXP-PPN1941262821  |e 4806050024 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"14 S.","noteIll":"Diagramme"}],"id":{"eki":["1941262821"],"doi":["10.1200/JCO.24.01118"]},"title":[{"subtitle":"long-term outcomes of adjuvant therapy in the ESPAC4 phase III Trial","title_sort":"Pancreatic adenocarcinoma","title":"Pancreatic adenocarcinoma"}],"person":[{"family":"Palmer","given":"Daniel","display":"Palmer, Daniel","role":"aut"},{"given":"Richard","display":"Jackson, Richard","role":"aut","family":"Jackson"},{"role":"aut","display":"Springfeld, Christoph","given":"Christoph","family":"Springfeld"},{"display":"Ghaneh, Paula","given":"Paula","role":"aut","family":"Ghaneh"},{"family":"Rawcliffe","given":"Charlotte","display":"Rawcliffe, Charlotte","role":"aut"},{"family":"Halloran","given":"Christopher M.","display":"Halloran, Christopher M.","role":"aut"},{"family":"Faluyi","display":"Faluyi, Olusola","given":"Olusola","role":"aut"},{"family":"Cunningham","display":"Cunningham, David","given":"David","role":"aut"},{"display":"Wadsley, Jonathan","given":"Jonathan","role":"aut","family":"Wadsley"},{"family":"Darby","given":"Suzanne","display":"Darby, Suzanne","role":"aut"},{"family":"Meyer","role":"aut","given":"Tim","display":"Meyer, Tim"},{"family":"Gillmore","role":"aut","display":"Gillmore, Roopinder","given":"Roopinder"},{"family":"Lind","role":"aut","display":"Lind, Pehr","given":"Pehr"},{"family":"Glimelius","display":"Glimelius, Bengt","given":"Bengt","role":"aut"},{"role":"aut","display":"Falk, Stephen","given":"Stephen","family":"Falk"},{"given":"Yuk Ting","display":"Ma, Yuk Ting","role":"aut","family":"Ma"},{"role":"aut","given":"Gary William","display":"Middleton, Gary William","family":"Middleton"},{"display":"Cummins, Sebastian","given":"Sebastian","role":"aut","family":"Cummins"},{"family":"Ross","role":"aut","display":"Ross, Paul J.","given":"Paul J."},{"role":"aut","given":"Harpreet","display":"Wasan, Harpreet","family":"Wasan"},{"family":"McDonald","role":"aut","display":"McDonald, Alec","given":"Alec"},{"family":"Crosby","role":"aut","given":"Tom","display":"Crosby, Tom"},{"family":"Hammel","display":"Hammel, Pascal","given":"Pascal","role":"aut"},{"given":"David","display":"Borg, David","role":"aut","family":"Borg"},{"role":"aut","display":"Sothi, Sharmila","given":"Sharmila","family":"Sothi"},{"given":"Juan W.","display":"Valle, Juan W.","role":"aut","family":"Valle"},{"family":"Mehrabi","role":"aut","display":"Mehrabi, Arianeb","given":"Arianeb"},{"family":"Bailey","role":"aut","given":"Peter","display":"Bailey, Peter"},{"family":"Tjaden","role":"aut","display":"Tjaden, Christine","given":"Christine"},{"family":"Michalski","display":"Michalski, Christoph","given":"Christoph","role":"aut"},{"role":"aut","display":"Hackert, Thilo","given":"Thilo","family":"Hackert"},{"family":"Büchler","given":"Markus W.","display":"Büchler, Markus W.","role":"aut"},{"display":"Neoptolemos, John P.","given":"John P.","role":"aut","family":"Neoptolemos"}],"language":["eng"],"name":{"displayForm":["Daniel H. Palmer, Richard Jackson, Christoph Springfeld, Paula Ghaneh, Charlotte Rawcliffe, Christopher M. Halloran, Olusola Faluyi, David Cunningham, Jonathan Wadsley, Suzanne Darby, Tim Meyer, Roopinder Gillmore, Pehr Lind, Bengt Glimelius, Stephen Falk, Yuk Ting Ma, Gary William Middleton, Sebastian Cummins, Paul J. Ross, Harpreet Wasan, Alec McDonald, Tom Crosby, Pascal Hammel, David Borg, Sharmila Sothi, Juan W. Valle, Arianeb Mehrabi, Peter Bailey, Christine Tjaden, Christoph Michalski, Thilo Hackert, Markus W. Büchler, and John P. Neoptolemos"]},"type":{"media":"Online-Ressource","bibl":"article-journal"},"relHost":[{"recId":"313116962","pubHistory":["1.1983 -"],"origin":[{"dateIssuedKey":"1983","publisher":"American Society of Clinical Oncology ; Lippincott Williams & Wilkins","dateIssuedDisp":"1983-","publisherPlace":"Alexandria, Va. ; Baltimore, Md. [u.a.]"}],"note":["Fortsetzung der Druck-Ausgabe","Gesehen am 22.05.23"],"id":{"zdb":["2005181-5"],"eki":["313116962"],"issn":["1527-7755"]},"language":["eng"],"titleAlt":[{"title":"official journal of the American Society of Clinical Oncology"},{"title":"JCO"},{"title":"Journal of clinical oncology legacy archive (ASCO)"}],"corporate":[{"display":"American Society of Clinical Oncology","role":"isb"}],"physDesc":[{"extent":"Online-Ressource"}],"disp":"Pancreatic adenocarcinoma long-term outcomes of adjuvant therapy in the ESPAC4 phase III TrialJournal of clinical oncology","part":{"text":"43(2025), 10, Seite 1240-1253","year":"2025","pages":"1240-1253","issue":"10","volume":"43","extent":"14"},"title":[{"subtitle":"JCO : an American Society of Clinical Oncology journal","title_sort":"Journal of clinical oncology","title":"Journal of clinical oncology"}],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"recId":"1941262821","note":["Online veröffentlicht: 4. Dezember 2024","Gesehen am 14.11.2025"],"origin":[{"dateIssuedDisp":"2025","dateIssuedKey":"2025"}]} 
SRT |a PALMERDANIPANCREATIC2025 

Similar Items